JPS57136555A - Novel peptide and its preparation - Google Patents

Novel peptide and its preparation

Info

Publication number
JPS57136555A
JPS57136555A JP57000142A JP14282A JPS57136555A JP S57136555 A JPS57136555 A JP S57136555A JP 57000142 A JP57000142 A JP 57000142A JP 14282 A JP14282 A JP 14282A JP S57136555 A JPS57136555 A JP S57136555A
Authority
JP
Japan
Prior art keywords
carboxy
carbamoyl
salt
compound expressed
formulai
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57000142A
Other languages
English (en)
Other versions
JPH068268B2 (ja
Inventor
Shinji Hashimoto
Yoshihiko Kitaura
Osamu Nakaguchi
Keiji Henmi
Shuichi Takeno
Tatsu Okada
Satoshi Yonishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of JPS57136555A publication Critical patent/JPS57136555A/ja
Publication of JPH068268B2 publication Critical patent/JPH068268B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP57000142A 1980-12-31 1981-12-25 新規ペプチド及びその製造方法 Expired - Lifetime JPH068268B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8041627 1980-12-31
GB8041627 1980-12-31
GB8111797 1981-04-14
GB8111797 1981-04-14

Publications (2)

Publication Number Publication Date
JPS57136555A true JPS57136555A (en) 1982-08-23
JPH068268B2 JPH068268B2 (ja) 1994-02-02

Family

ID=26278010

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57000142A Expired - Lifetime JPH068268B2 (ja) 1980-12-31 1981-12-25 新規ペプチド及びその製造方法

Country Status (10)

Country Link
US (1) US4493794A (ja)
EP (1) EP0055846B1 (ja)
JP (1) JPH068268B2 (ja)
AU (1) AU7913481A (ja)
CA (1) CA1247084A (ja)
DE (1) DE3174158D1 (ja)
DK (1) DK577281A (ja)
ES (1) ES8304923A1 (ja)
GR (1) GR75126B (ja)
HU (1) HU188120B (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03120245A (ja) * 1989-09-28 1991-05-22 Hoechst Ag レトロウイルスプロテアーゼの阻害剤
JP2009007357A (ja) * 1996-07-22 2009-01-15 F Hoffmann La Roche Ag 抗腫瘍剤としてのポリアミン配位子を有する新規ビス−プラチナ錯体

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4565653A (en) * 1984-03-30 1986-01-21 Pfizer Inc. Acyltripeptide immunostimulants
GB9022301D0 (en) * 1990-10-15 1990-11-28 Myson Group Plc Heater assembly

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5576850A (en) * 1978-10-19 1980-06-10 Anvar Waterrsoluble compounds derived from extract of streptomyces stimulosus*their manufactures and immunologic adjuvant composition
JPS5585552A (en) * 1978-11-14 1980-06-27 Fujisawa Pharmaceut Co Ltd New lactyltetrapeptide
JPS55106279A (en) * 1979-02-08 1980-08-14 Dow Corning Primer composition
JPS55140883A (en) * 1973-01-08 1980-11-04 Tektronix Inc Signal process indication unit
JPH0295412A (ja) * 1988-09-30 1990-04-06 Toyobo Co Ltd 中空糸膜型気体分離膜装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2033906B (en) * 1978-10-19 1982-12-01 Anvar Water-soluble compounds derived from extracts of streptomyces stimulosus process for their production and compositions containing them
US4311640A (en) * 1978-11-14 1982-01-19 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
FR2460290A1 (fr) * 1979-06-29 1981-01-23 Rhone Poulenc Ind Nouveaux tetra- ou pentapeptides, leur preparation et les medicaments qui les contiennent

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55140883A (en) * 1973-01-08 1980-11-04 Tektronix Inc Signal process indication unit
JPS5576850A (en) * 1978-10-19 1980-06-10 Anvar Waterrsoluble compounds derived from extract of streptomyces stimulosus*their manufactures and immunologic adjuvant composition
JPS5585552A (en) * 1978-11-14 1980-06-27 Fujisawa Pharmaceut Co Ltd New lactyltetrapeptide
JPS55106279A (en) * 1979-02-08 1980-08-14 Dow Corning Primer composition
JPH0295412A (ja) * 1988-09-30 1990-04-06 Toyobo Co Ltd 中空糸膜型気体分離膜装置

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03120245A (ja) * 1989-09-28 1991-05-22 Hoechst Ag レトロウイルスプロテアーゼの阻害剤
JP2009007357A (ja) * 1996-07-22 2009-01-15 F Hoffmann La Roche Ag 抗腫瘍剤としてのポリアミン配位子を有する新規ビス−プラチナ錯体

Also Published As

Publication number Publication date
CA1247084A (en) 1988-12-20
HU188120B (en) 1986-03-28
DE3174158D1 (en) 1986-04-24
JPH068268B2 (ja) 1994-02-02
EP0055846B1 (en) 1986-03-19
US4493794A (en) 1985-01-15
EP0055846A1 (en) 1982-07-14
DK577281A (da) 1982-07-01
AU7913481A (en) 1982-07-08
ES508467A0 (es) 1983-03-16
GR75126B (ja) 1984-07-13
ES8304923A1 (es) 1983-03-16

Similar Documents

Publication Publication Date Title
PL250350A1 (en) Process for preparing 4"-epi-9-desketo-9a-methyl-9a-aza-9a-homoerythromycin a
HUT50345A (en) Process for production of cefem-derivatives and their intermediers
JPS5777689A (en) Novel cephen compound, or its salt, its preparation, and preventive it as active ingredient
JPS6425779A (en) (1r,5s,6s)-2-substituted-thio-6-((r)-1-hydroxyethyl)-1-methyl -carbapenem-3-carboxylic acid derivative
JPS57176988A (en) Penam-3-carboxylic acid derivative and its preparation
JPS5543011A (en) 7-halothiazolylalkoxyiminoacetamido-3-cephem compound
JPS57136555A (en) Novel peptide and its preparation
IE781568L (en) Cyclopeptide antibiotic
JPS57114556A (en) Novel peptide compound and its preparation
AU548292B2 (en) 3-3-demethyl derivatives of istamycin b series compounds
JPS5775994A (en) Novel aprosamine derivative
JPS57145845A (en) Novel peptide and its preparation
JPS55329A (en) Novel xk-62-4 derivative
JPS57118544A (en) Novel peptide and its preparation
JPS5681598A (en) Gentamicin derivative
ATE15049T1 (de) Makrolide antibiotika aus streptomyces.
JPS57108050A (en) Novel peptide and its preparation
JPS57118560A (en) Preparation of 1-sulfo-2-oxoazetidine and its intermediate
JPS57140752A (en) Novel peptide, its preparation and use
ES8602670A1 (es) Un derivado de acido 4-oxo-1,4-dihidronicotinico o sus sales
JPS57175192A (en) 7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivative
JPS55167297A (en) Leucomycin derivative and its derivative
JPS55151597A (en) New material 2-hydroxysagamicin and its preparation
JPS55164691A (en) Novel 7-methoxycephalosporanic acid derivative, its optically active substance, its salt, and its preparation
JPS56127382A (en) Beta-lactam compound and its preparation